Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AZD3759 + Radiotherapy |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AZD3759 | AZD-3759|zorifertinib | EGFR Inhibitor (Pan) 63 | AZD3759 inhibits EGFR, potentially resulting in decreased growth of EGFR-expressing tumors and is also able to fully penetrate the blood-brain barrier (PMID: 27928026, PMID: 29430654). | |
| Radiotherapy |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|